Conversely, Tβ4 and BMP4 overexpression in hepatocytes can upregulate GPX4 expression, thereby inhibiting ferroptosis, reducing hepatic oxidative stress and lipid peroxidation, and providing protection against NAFLD/NASH [200, 201]. Here, GPX4 is linked to metabolic dysfunction-associated steatohepatitis.